Company Snapshot

Investment Thesis

McKesson is a leading pharma distributor and healthcare technology provider. Scale distribution, oncology practice support, and specialty logistics underpin steady cash flow and growing share repurchases.

  • Specialty Focus: Oncology and biopharma services deepen wallet share beyond distribution.
  • Technology & Analytics: CoverMyMeds and data solutions streamline specialty access and adherence.
  • Capital Discipline: Asset-light model generates cash for dividends and large buybacks.

Strategic Mix

U.S. Pharmaceutical Drug distribution to retail chains, independent pharmacies, and health systems
Medical-Surgical Solutions Supplies and logistics for ambulatory and home settings
Prescription Technology CoverMyMeds ePA, patient support, and hub services
International Canada and European distribution plus oncology partnerships

Mix references McKesson’s FY2024 segment structure.

Recent Performance

MTD TBD
QTD TBD
YTD TBD
5Y TBD

Maxim is cueing up returns data for this security. Once the nightly supported.csv job runs, these metrics will auto-populate.

Strategic Insights

Specialty Drugs

Growth in oncology, cell/gene therapies, and biosimilars supports margin expansion.

Value-Based Care

Data and hub services help practices succeed under alternative payment models.

Portfolio Simplification

Exiting low-return geographies sharpens focus on North America.

Latest Coverage

Curated headlines sourced from Maxim’s AI newsroom.

Loading latest coverage...